Variable | Total n (%) | Group A n (%) | Group B n (%) | p-value |
---|---|---|---|---|
Gender | ||||
Male | 46 (56.1) | 35 (61.4) | 11 (44) | |
Female | 36 (43.9) | 22 (38.6) | 14 (56) | 0.144 |
Age (years) | ||||
≤ 60 | 22 (26.8) | 17 (29.8) | 5 (20) | |
61–68 | 22 (26.8) | 16 (28.1) | 6 (24) | |
69–74 | 24 (29.3) | 15 (26.3) | 8 (32) | |
≥ 75 | 14 (17.1) | 9 (15.8) | 6 (24) | 0.666 |
Type of liver disease | ||||
No cirrhosis or HCC | 45 (54.9) | 34 (59.6) | 9 (36) | |
Cirrhosis | 35 (42.7) | 23 (40.4) | 14 (56) | |
HCC with cirrhosis | 2 (2.4) | 0 (0) | 2 (8) | 0.025 |
Transient elastography | ||||
None | 7 (8.5) | |||
F0 | 0 (0) | 0 (0) | 0 (0) | |
F1 | 2 (2.4) | 2 (3.9) | 0 (0) | |
F2 | 3 (3.8) | 3 (5.9) | 0 (0) | |
F3 | 33 (40.2) | 29 (56.9) | 3 (13) | |
F4 | 37 (45.1) | 17 (33.3) | 20 (87) | < 0.01 |
HCV Genotype | ||||
1a | 2 (2.4) | 1 (1.7) | 1 (4) | |
1b | 60 (73.3) | 42 (73.7) | 17 (68) | |
2 | 6 (7.3) | 3 (5.3) | 3 (12) | |
2a/2c | 5 (6.1) | 6 (10.5) | 0 (0) | |
3 | 4 (4.8) | 1 (1.7) | 3 (12) | |
4 | 5 (6.1) | 4 (7.1) | 1 (4) | 0.148 |
Co-infections | ||||
None | 81 (98.8) | 56 (98.3) | 25 (100) | |
HIV + | 1 (1.2) | 1 (1.7) | 0 (0) | |
HBsAg +/HIV - | 0 (0) | 0 (0) | (0) | 0.505 |
BMI | ||||
Normal | 23 (28) | 18 (31.6) | 5 (20) | |
Overweight/Obese | 59 (71.0) | 39 (68.4) | 20 (80) | 0.283 |
Risk factors for CV diseasesa | ||||
None | 19 (23.2) | 15 (26.3) | 4 (16) | 0.308 |
Hypertension | 51 (62.2) | 34 (59.6) | 17 (68) | 0.473 |
Diabetes mellitus | 21 (25.6) | 12 (21.1) | 8 (32) | 0.288 |
Smoking habits | 14 (17.1) | 11 (19.3) | 3 (12) | 0.419 |
Previous CV events | 4 (4.8) | 3 (5.3) | 1 (4) | 0.807 |
Comorbiditiesa | ||||
None | 19 (23.2) | 15 (26.3) | 4 (16) | 0.308 |
eGFR < 90 ml/min | 43 (52.4) | 32 (39) | 11 (13.4) | 0.350 |
Osteoporosis | 15 (18.3) | 10 (17.6) | 5 (20) | 0.791 |
Depression | 14 (17.1) | 11 (19.3) | 3 (12) | 0.419 |